Moderna, Inc. (MRNA) Stock: Slide as Company Upsizes Debt Offering to $2.6 Billion

TLDR Moderna upsizes its convertible notes offering to $2.6 billion as MRNA shares fall. MRNA closes 4.60% lower as Moderna expands its convertible debt financing plan. The notes carry a 0.00% rate and an initial conversion price of about $210.58. Moderna expects up to $2.96 billion in net proceeds if the full option is used. [...]

The post Moderna, Inc. (MRNA) Stock: Slide as Company Upsizes Debt Offering to $2.6 Billion appeared first on Blockonomi.